U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07392034) titled 'Efficacy of Tranexamic Acid Reducing Blood Loss During Maxillofacial Trauma Surgery' on Jan. 19.
Brief Summary: Tranexamic acid (TXA) is an inexpensive, easily used and relatively safe drug. It inhibits plasminogen activation and plasmin thus retards clot disintegration.Therapeutic application of tranexamic acid in trauma for preventing blood loss has been documented since long. Since blood loss causes several serious complications, it is compensated emergently by transfusion of blood or its products. However, transfusion of blood and products always carries a risk of inadvertent transmission of infection, antigen-antibody reactions ...